THIS IS MORE THAN HOPE
Patients diagnosed with non-Hodgkin lymphoma are told they’ll achieve remission with first-line chemotherapy. But about 50% of them don’t, as their cancer resists treatment after treatment. They are running out of options…and hope. They need a reason to believe complete remission can still exist after treatment failure. YESCARTA is the first CAR T-cell therapy approved for NHL. It can give appropriate 3rd-line patients something more than hope––it can give them a chance for complete remission. With a website that emphasizes empathy, education, and empowerment, we are able to provide patients the resources they need to fight for their survival.
Our goal was to give patients not only hope, but a chance for real remission. Together, with patients and oncologists, we are all succeeding.
DIGITAL THAT ENGAGES AND EMPOWERS
The YESCARTA homepage welcome patients with undulated emotion. A relatable scene, a clear brand promise, and actionable steps lead patients toward the therapy they need.
Real patients share their stories of hope and survival, helping YESCARTA gain credibility with the understandably wary. Gary, Humberto, and Sharon highlight how different each cancer journey can be, the diversity amongst them intended to appeal to a wider range of patients. Through their experiences, people with NHL find the courage to take the next step with YESCARTA.
As a third-line treatment, the path that leads to YESCARTA is complex. Patients aren’t sure when it’s an option, which makes obtaining a referral for treatment a key barrier. This interactive page guides patients through the NHL treatment journey explaining all of their options. By giving patients the tools to understand this complicated approval process, we are empowering them to advocate for a referral, or even self-refer, to a YESCARTA Authorized Treatment Center.
THE POWER OF PATIENT SELF ADVOCACY
Despite a very small patient population, YESCARTA made an outsized impact. These numbers represent more than campaign results—they represent lives saved.
PATIENT POPULATION: 8,400
281,699
UNIQUE SITE VISITS
5,186
DISCUSSION TOOL
DOWNLOADS
13,999
AUTHORIZED TREATMENT
CENTER SEARCHES